Pneumococcal proteins PspA and PspC induce CXCL8 production in human neutrophils: Implications in pneumococcal infections

Microbes and Infection

Volumn 12, Issue 12-13, 2010, Pages 1051-1060

  Cao, Ju ^a   Gong, Yi ^b   Yin, Yibing ^b   Wang, Lanlan ^a   Ying, Binwu ^a   Chen, Tingmei ^b   Zhang, Xuemei ^b  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

CXCL8; Neutrophil; Protein; Streptococcus pneumoniae

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN PSPA; PROTEIN PSPC; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

BACTERIAL PROTEINS; CELLS, CULTURED; GENE DELETION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-8; NEUTROPHILS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PNEUMOCOCCAL INFECTIONS; SIGNAL TRANSDUCTION;

STREPTOCOCCUS PNEUMONIAE;

EID: 77958086757     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.07.008     Document Type: Article

References (32)

1. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997, 15:675-705.
2. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
3. Bergmann S., Hammerschmidt S. Versatility of pneumococcal surface proteins. Microbiology 2006, 152:295-303.
4. Bernatoniene J., Zhang Q., Dogan S., Mitchell T.J., Paton J.C., Finn A. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases. J. Infect. Dis. 2008, 198:1823-1833.
5. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 2004, 4:144-154.
6. Briles D.E., Tart R.C., Swiatlo E., Dillard J.P., Smith P., Benton K.A., Ralph B.A., Brooks-Walter A., Crain M.J., Hollingshead S.K., McDaniel L.S. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 1998, 11:645-657.
7. Cao J., Chen D., Xu W., Chen T., Xu S., Luo J., Zhao Q., Liu B., Wang D., Zhang X., Shan Y., Yin Y. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 2007, 25:4996-5005.
8. Cockeran R., Durandt C., Feldman C., Mitchell T.J., Anderson R. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J. Infect. Dis. 2002, 186:562-565.
9. Cripps A.W., Leach A.J., Lehmann D. Pneumococcal vaccination in developing countries. Lancet 2006, 368:644.
10. Cuenda A., Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375.
11. Graham R.M., Paton J.C. Differential role of CbpA and PspA in modulation of in vitro CXC chemokine responses of respiratory epithelial cells to infection with Streptococcus pneumoniae. Infect. Immun. 2006, 74:6739-6749.
12. N'Guessan P.D., Hippenstiel S., Etouem M.O., Zahlten J., Beermann W., Lindner D., Opitz B., Witzenrath M., Rosseau S., Suttorp N., Schmeck B. Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L1131-L1138.
13. Farnworth S.L., Henderson N.C., Mackinnon A.C., Atkinson K.M., Wilkinson T., Dhaliwal K., Hayashi K., Simpson A.J., Rossi A.G., Haslett C., Sethi T. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am. J. Pathol. 2008, 172:395-405.
14. Feldman C., Mitchell T.J., Andrew P.W., Boulnois G.J., Read R.C., Todd H.C., Cole P.J., Wilson R. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb. Pathog. 1990, 9:275-284.
15. Foley S.C., Hamid Q. Images in allergy and immunology: neutrophils in asthma. J. Allergy Clin. Immunol. 2007, 119:1282-1286.
16. Hammerschmidt S., Bethe G., Remane P.H., Chhatwal G.S. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect. Immun. 1997, 67:1683-1687.
17. Huber A.R., Kunkel S.L., Todd R.F., Weiss S.J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254:99-102.
18. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 2008, 6:288-301.
19. Khan A.Q., Shen Y., Wu Z.Q., Wynn T.A., Snapper C.M. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect. Immun. 2002, 70:749-761.
20. King Q.O., Lei B., Harmsen A.G. Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection. J. Infect. Dis. 2009, 200:537-545.
21. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2002, 2:721-736.
22. 2+-dependent production and release of IL-8 in human neutrophils. J. Immunol. 1998, 161:4332-4339.
23. Laskay T., van Zandbergen G., Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 2008, 213:183-191.
24. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
25. Lu L., Ma Y., Zhang J.R. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 2006, 281:15464-15474.
26. McDaniel L.S., Yother J., Vijayakumar M., McGarry L., Guild W.R., Briles D.E. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 1987, 165:381-394.
27. Navarini A.A., Lang K.S., Verschoor A., Recher M., Zinkernagel A.S., Nizet V., Odermatt B., Hengartner H., Zinkernagel R.M. Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7107-7112.
28. Meng J.P., Yin Y.B., Zhang X.M., Huang Y.S., Lan K., Cui F., Xu S.X. Identification of Streptococcus pneumoniae genes specifically induced in mouse lung tissues. Can. J. Microbiol. 2008, 54:58-65.
29. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene " intercrine" cytokine family. Annu. Rev. Immunol. 1991, 9:617-648.
30. Shaper M., Hollingshead S.K., Benjamin W.H., Briles D.E. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect. Immun. 2004, 72:5031-5040.
31. Beisswenger C., Coyne C.B., Shchepetov M., Weiser J.N. Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J. Biol. Chem. 2007, 282:28700-28708.
32. Xu F., Droemann D., Rupp J., Shen H., Wu X., Goldmann T., Hippenstiel S., Zabel P., Dalhoff K. Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. Am. J. Respir. Cell Mol. Biol. 2008, 39:522-529.